RxDoctor Payments Data

Angela Aldrich, MD

Obstetrics & Gynecology · Sioux City, IANPI 1679570576

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,537 of the $2,836 with a category attached, or 89.5%. 25 manufacturers reported payments, led by Astellas Pharma US Inc at 29.0% of the total.

$2,836in general payments, 2019–2025

Across 144 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$823
  • AbbVie$489
  • Sumitomo Pharma America, Inc.$269
  • Mayne Pharma Commercial LLC$130
  • Merck$117
  • Myovant Sciences Inc.$105
  • plus $904 from 19 others

What the payments were for

  • Food & beverage$2,53789%
  • Education$29911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,836 in reported general payments places this provider in the 85th percentile of 274 obstetrics & gynecology providers in Iowa.

See all obstetrics & gynecology providers in Iowa

Medicare billing

Part B allowed, 2024
$17,128
Medicare patients
95
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IntrarosaPrasterone (Dhea)12$3,627
Estradiol21$608

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →